Effects of Lecanemab in Chinese Patients with Early Alzheimer's Disease: Evidence from a Multidimensional Real‐World Study

Abstract

Background: Lecanemab has shown promise in treating early Alzheimer’s disease (AD), but its efficacy and safety in Chinese populations remain unexplored.

The paper